Related Experiment Video
Updated: Jun 15, 2025

08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.2K
Circular RNA, A Molecule with Potential Chemistry and Applications in RNA-based Cancer Therapeutics: An Insight into
Zahra Shafaghat1, Safa Radmehr2, Saber Saharkhiz3
1Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Topics in Current Chemistry (Cham)
|May 9, 2025
Summary
Circular RNAs (circRNAs) are stable, non-coding RNA molecules involved in gene regulation. Their unique structure and role in cancer highlight their potential as diagnostic biomarkers and therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Non-coding RNAs (ncRNAs) regulate gene expression without protein synthesis.
- Circular RNAs (circRNAs) are a distinct class of ncRNAs with a stable, covalently closed structure.
- CircRNAs play crucial roles in gene regulation, similar to microRNAs (miRNAs) and long non-coding RNAs (lncRNAs).
Purpose of the Study:
- To explore the biogenesis and functions of circRNAs.
- To investigate the involvement of circRNAs in cancer development and progression.
- To discuss the potential of circRNAs as diagnostic biomarkers and therapeutic agents.
Main Methods:
- Review of existing literature on circRNA biogenesis and function.
- Analysis of circRNA involvement in cancer hallmarks.
- Discussion of circRNA applications in diagnostics and therapeutics.
Main Results:
- CircRNAs are formed via reverse splicing and are highly stable due to their circular structure.
- Five main types of circRNAs exist: exon circRNAs, circular intronic RNAs, exon-intron circRNAs, intergenic circRNAs, and fusion circRNAs.
- CircRNAs significantly impact cancer hallmarks like proliferation, angiogenesis, and metastasis.
Conclusions:
- CircRNAs are key regulators of gene expression with implications in cancer.
- Their stability and regulatory functions make them promising candidates for cancer diagnostics and therapeutics.
Related Concept Videos
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K

